Human Metapneumovirus Infection
📧 Sign up to get email alerts when something new happens for Human Metapneumovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 clinical trial update for PUL-042 in patients with parainfluenza virus, human metapneumovirus, or respiratory syncytial virus infect…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults [Phase 1]
Phase 1 clinical trial update for VXB-251, a trivalent vaccine targeting RSV, human metapneumovirus, and parainfluenza virus type 3, studied…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older [Phase 1, Phase 2]
Phase 1/2 study of Sanofi Pasteur's lipid nanoparticle-encapsulated mRNA vaccine candidate for human metapneumovirus and respiratory syncyti…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months [Phase 1]
Clinical trial update describing safety, tolerability, and immunogenicity assessment of Moderna’s mRNA vaccines mRNA-1345 and mRNA-1365 in i…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults [Phase 1]
Phase 1 study of VXB-241, an RSV-HMPV bivalent vaccine, conducted by Vicebio Australia Proprietary Limited. The trial's listed population is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]
This document describes an early-phase, first-in-human safety and immunogenicity study of the vaccine candidates SCB-1022 and SCB-1033 in he…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans® [Phase 1]
A Phase 1 study evaluating ProTrans for treating respiratory complications associated with COVID-19, influenza A, human metapneumovirus, and…